Document |
Document Title |
WO/2020/235336A1 |
This compound is represented by formula (1). MaXbYc (1) (In formula (1), M represents a metal other than an alkali metal, X represents -N(SO2F)2, Y represents a coordinating solvent, and a, b, and c are positive numbers.)
|
WO/2020/230555A1 |
A method for forming a carbon-carbon bond, wherein: a reaction is performed by filling a container with a platinum group metal-loaded catalyst and having a starting material liquid permeate through the platinum group metal-loaded catalys...
|
WO/2020/228359A1 |
The present invention relates to the field of organic optoelectronic materials, and disclosed are an organic light-emitting material containing tetraphenylbenzene, preparation, and an application. The organic light-emitting material cont...
|
WO/2020/230480A1 |
The present invention addresses the problem of providing: a polymerizable liquid crystal composition that can undergo uniform vertical alignment without a PI layer being provided, can inhibit occurrence of dropping marks or alignment irr...
|
WO/2020/221238A1 |
Provide an aptamer nucleic acid molecule, and a complex containing said aptamer nucleic acid molecule and a small fluorophore molecule; the aptamer nucleic acid molecule is used for detecting RNA, DNA, or other target molecules inside or...
|
WO/2020/221217A1 |
A fluorescent dye, a preparation method therefor, and a use thereof; the fluorescent dye is sensitive and specific to viscosity response, has the advantage of low background fluorescence, and can be used as a fluorescence activated dot l...
|
WO/2020/212583A1 |
This invention relates to a process for producing cyanoacetates using a cyanoacetamide as a precursor.
|
WO/2020/212543A1 |
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive unit, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and ophthalm...
|
WO/2020/212584A1 |
This invention relates to a process for producing cyanoacetates using asparagine as a precursor to cyanoacetamide, a staring material to form the cyanoacetates.
|
WO/2020/214853A1 |
The present disclosure provides certain tetrahydro-lH-cyclopenta[cd]indene compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Al...
|
WO/2020/213361A1 |
The present invention pertains to a catalyst that includes molybdenum, bismuth, iron, and nickel, wherein the ratio of surface nickel concentration to bulk nickel concentration is 0.60-1.20.
|
WO/2020/212585A1 |
This invention relates to a process for producing cyanoacetates using aspartic acid as a precursor.
|
WO/2020/212872A1 |
There is provided a metal or metal-ion battery comprising an aluminum current collector and a low-corrosiveness non-aqueous electrolyte comprising, as a solvent, a carbonate compound of formula (I): (I). This battery has an upper voltage...
|
WO/2020/213362A1 |
A catalyst that comprises Mo, Bi, and Fe and satisfies the requirements 0.10
|
WO/2020/199079A1 |
Provided are a novel conjugated triene compound 1, a preparation method therefor and use thereof. The conjugated triene compound 1 is obtained by successively subjecting a 2-(cyclohexenylene) malonic acid derivative compound as a raw mat...
|
WO/2020/200290A1 |
Disclosed is a meta-diamide compound and an application thereof. The structure of the compound is represented by general formula I. The definition of each substituent in the formula is provided in the specification. The compound represen...
|
WO/2020/200952A1 |
The present invention pertains to a process for preparing 3-hydroxy-3-methylbutyrate (HMB) or a salt thereof, the method comprising (a) reacting isobutylene oxide with cyanide in order to obtain 3- hydroxy-3-methylbutyronitrile, and (b) ...
|
WO/2020/199081A1 |
The present invention provides a method for preparing a 2-arylmalonic acid derivative, an intermediate, and an application thereof. In the method, a cyclohexadiene compound is taken as a raw material, and isomerization reaction, halogena...
|
WO/2020/199078A1 |
Provided by the present invention are a novel halogenated conjugated diene compound 1, a preparation method therefor and use thereof. The compound 1 can be obtained by subjecting a conjugated diene compound as a raw material to halogenat...
|
WO/2020/205470A1 |
The present disclosure provides compounds and methods for inhibiting or degrading the N-terminal domain of the androgen receptor, as well as methods for treating cancers such as prostate cancer.
|
WO/2020/203581A1 |
A method for producing a nitrile compound, comprising: a first step for introducing, into a reactor, a material gas that includes a cyclic compound having an organic substituent, ammonia and air, and generating a nitrile compound by reac...
|
WO/2020/197875A1 |
The disclosure provides processes for preparing a compound of formula I, comprising reacting a compound of formula II with an aqueous acid in a solvent and at a temperature sufficient for at least about 48 hours to produce a compound of ...
|
WO/2020/193387A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.
|
WO/2020/192348A1 |
Disclosed are phenyl allylidene cyclohexenone derivatives with the structure shown in general formula I. In combination with structural characteristics and structure-function relationship of piplartine, amino bonds are replaced with doub...
|
WO/2020/185420A1 |
Provided herein are integrated methods and systems for the production of acrylamide and acrylonitrile compounds and other compounds from at least beta-lactones and/or beta-hydroxy amides.
|
WO/2020/184330A1 |
A catalyst for acrylonitrile synthesis, which contains a composite body of a metal oxide and a silica that supports the metal oxide, and which is configured such that the ratio of the specific surface area B of the catalyst for acrylonit...
|
WO/2020/179671A1 |
This invention provides: a curable resin composition including a specific polymer precursor, a nonionic compound B, and at least one compound selected from the group consisting of a polymerizable compound and a photosensitive compound, w...
|
WO/2020/181165A1 |
Provided herein are compounds of formula (I), compositions comprising the compounds and method of treating various diseases with the compounds and compositions.
|
WO/2020/177140A1 |
An acrylonitrile catalyst, a preparation method therefor, and application thereof. The acrylonitrile catalyst contains a metal oxide represented by the following general formula: BiaFebNicMgdCeeAfBgChMo12Ox, wherein A is one or more elem...
|
WO/2020/173016A1 |
The present invention relates to a resorcinol dianisole derivative, wherein the chemical structure of this compound is as represented by the following formula (I). The compound of the present invention can inhibit the binding of programm...
|
WO/2020/175392A1 |
A compound which has a molecular weight of 3,000 or less, while having a partial structure that is represented by formula (X). (In formula (X), ring W1 represents a ring structure that does not have aromaticity, while having at least one...
|
WO/2020/175393A1 |
A compound represented by general formula (I). [In formula (I), R3, R4, and R5 each independently represent an electron-attracting group. R1, R2, R6, and R7 each independently represent a hydrogen atom, a heterocyclic group, a halogen at...
|
WO/2020/172562A1 |
The present disclosure relates to a process for stabilizing an antimony ammoxidation catalyst in an ammoxidation process. The process may comprise providing an antimony ammoxidation catalyst to a reactor; reacting propylene with ammonia ...
|
WO/2020/169047A1 |
Disclosed in the present invention is a 1,1-dicyanohydrazone compound having a novel structure, the structure being as shown in general formula I. See the description for the definitions of each substituent in the formula. The compound o...
|
WO/2020/163653A1 |
Improved processes and intermediates for preparing ruxolitinib and deuterated analogs of ruxolitinib are disclosed.
|
WO/2020/156297A1 |
Disclosed is a malononitrile compound having a novel structure. The structure is shown in general formula I. See the description for the definition of each substituents in the formula. The compound of general formula I has excellent bact...
|
WO/2020/156298A1 |
Disclosed by the present invention is an application of a malononitrile compound as represented by general formula I as a bactericide. See the description for the definition of each substituent in the formula. The compound represented by...
|
WO/2020/153414A1 |
The purpose of the present invention is to provide a heterocyclic compound that can have an antagonist activity against an NMDA receptor including an NR2B subunit and is thus expected to be useful as a prophylactic or therapeutic agent f...
|
WO/2020/150969A1 |
The present invention provides a diallyl phtalate monomer synthesis method, and belongs to the novel technical field of preparation of high molecular weight monomer by polymerization. An acrylate monomer having a phthalonitrile structure...
|
WO/2020/148617A1 |
The present invention disclosed 3-substituted phenylamidine compounds of general formula (I), wherein R1, R2, R3, R4, R4a, R4b, A and E have the same meanings as defined in description. The present invention further discloses methods for...
|
WO/2020/148760A1 |
The invention generally concerns a novel class of CB 1 receptor binding molecules and uses thereof.
|
WO/2020/143762A1 |
Provided are pamoate salts of ketamine having a stoichiometry of 2: 1 of ketamine to pamoate, including R, S-ketamine pamoate, S-ketamine pamoate, or R-ketamine pamoate, and crystalline or amorphous forms of the pamoate salts, and having...
|
WO/2020/127208A2 |
The present disclosure concerns the large-scale manufacture of pharmaceutical compounds, and novel intermediates for use in the manufacture. International Patent Application WO2011154737 discloses morpholine pyrimidines useful for treati...
|
WO/2020/119507A1 |
The present application relates to a method for citalopram intermediate 5-citalopram diol. The method comprises: first mixing two Grignard reagents required for a reaction; then mixing the mixed Grignard reagents with a raw material 5-cy...
|
WO/2020/104484A1 |
The present invention relates to the synthesis of N-trifluoromethylcarbonyl compounds starting from isothiocyanates, which can be converted into N-trifluoromethylcarbamoyl fluorides or similar compounds, which later on can be derivatized...
|
WO/2020/102289A1 |
A process for producing a high-purity acetonitrile product from a low-purity acetonitrile feedstock streams. In particular, the present disclosure relates to a process for producing a sales-grade, high purity acetonitrile by (a) distilli...
|
WO/2020/102716A1 |
Disclosed herein a process preparation of 2,6-dichlorobenzonitrile. A process of making high yield, high purity 2,6-dichlorobenzonitrile including the selective de-nitrochlorination of 2-chloro-6-nitrobenzonitrile by treatment of the 2-c...
|
WO/2020/094928A1 |
The present disclosure relates to a process for the preparation of 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile, to use of a compound which is 2-methoxy-5-(4-methylbenzyl)phenol, (3-hydroxy-4-methoxyphenyl)(p-tolyl)methanone, 2-meth...
|
WO/2020/087233A1 |
Disclosed is an application of an ionic iron (III) complex as a catalyst in preparation of a benzylamine compound, that is, an ionic iron (III) complex having a molecular formula of [(RNCHCHNR)CH][FeBr4] (R is tert-butyl) and containing ...
|
WO/2020/085335A1 |
This production method for a 2-cyanoacrylate compound includes: a depolymerization step for depolymerizing a 2-cyanoacrylate polycondensate that is a condensate of a cyanoacetic acid ester compound and a formaldehyde compound in the pres...
|